Emerging strategies in the management of ATTR amyloidosis
Richard Cheng, MD, MSc Associate Professor of Medicine; Attending Physician University of Washington
▶︎
ATTR Cardiac Amyloidosis
▶︎
Cardiac Arrest – Finding (and Moving) the Needle Within the Haystack
▶︎
Contemporary Limitations of TMVR: Mitigating Anatomic Challenges in a Land of Increasing Options
▶︎
AI at the Point-of-Care: How good is it?
▶︎
Advanced Prostate Cancer Treatment Options: New Therapies, Genetic Testing, and Emerging Research
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Wild Type ATTR Amyloidosis: Paul’s Story
▶︎
What can FIDO teach us about slowing human aging?
▶︎
The Future for Patients with ATTR Cardiac Amyloidosis is Brighter
▶︎
Palliative Care: Mastering patient & family-centered care across cardiovascular disease
▶︎
Understanding Cardiac Amyloidosis: Evaluation and Diagnosis w/ Mathew S. Maurer, MD
▶︎
Cardiac Point of Care Ultrasound. Applications in Underserved Populations.
▶︎
Septal Reduction Therapy in Hypertrophic Cardiomyopathy: Current Approaches and Novel Strategies
▶︎
IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis
▶︎
10 - Neurological Presentations of ATTR | Updates in Cardiac Amyloidosis 2023
▶︎
The Most Misunderstood Concept in Physics
▶︎
Apparently Idiopathic PVCs: When are they confidently idiopathic?
▶︎
T1 & T2 Mapping in Cardiac MRI: Clinical Applications
▶︎
Wild-Type Transthyretin Cardiac Amyloidosis - Mayo Clinic
▶︎